T-cell receptor profiling in cancer

Molecular Oncology

Volumn 9, Issue 10, 2015, Pages 2063-2070

  Kirsch, Ilan ^a   Vignali, Marissa ^a   Robins, Harlan ^a,b  

^a ADAPTIVE BIOTECHNOLOGIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Ig TCR sequence biomarkers; Immunosequencing; Lymphoid clonality assessment tracking

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

AUTOIMMUNITY; CANCER IMMUNOLOGY; CLONAL VARIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; LEUKEMIA; LYMPHOMA; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; VACCINATION; IMMUNOLOGY;

HUMANS; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL;

EID: 84952637397     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.09.003     Document Type: Review

References (35)

1. Bertness V., Kirsch I., Hollis G., Johnson B., Bunn P.A. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N. Engl. J. Med. 1985, 313:534-538.
2. Bunge J., Fitzpatrick M. Estimating the number of species: a review. J. Am. Stat. Assoc. 1993, 88:364-373.
3. Calis J.J., Rosenberg B.R. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 2014, 35:581-590.
4. Carlson C.S., Emerson R.O., Sherwood A.M., Desmarais C., Chung M.W., Parsons J.M., Steen M.S., LaMadrid-Herrmannsfeldt M.A., Williamson D.W., Livingston R.J., Wu D., Wood B.L., Rieder M.J., Robins H. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 2013, 4:2680.
5. Cooper Z.A., Frederick D.T., Juneja V.R., Sullivan R.J., Lawrence D.P., Piris A., Sharpe A.H., Fisher D.E., Flaherty K.T., Wargo J.A. BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology 2013, 2:e26615.
6. Davila M.L., Bouhassira D.C., Park J.H., Curran K.J., Smith E.L., Pegram H.J., Brentjens R. Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int. J. Hematol. 2014, 99:361-371.
7. DeWitt W.S., Emerson R.O., Lindau P., Vignali M., Snyder T.M., Desmarais C., Sanders C., Utsugi H., Warren E.H., McElrath J., Makar K.W., Wald A., Robins H.S. Dynamics of the cytotoxic T cell response to a model of acute viral infection. J. Virol. 2015, 89:4517-4526.
8. Emerson R., Sherwood A., Desmarais C., Malhotra S., Phippard D., Robins H. Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data. J. Immunol. Methods 2013, 391:14-21.
9. Emerson R.O., Sherwood A.M., Rieder M.J., Guenthoer J., Williamson D.W., Carlson C.S., Drescher C.W., Tewari M., Bielas J.H., Robins H.S. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J. Pathol. 2013, 231:433-440.
10. Emerson R., DeWitt W., Vignali M., Gravley J., Desmarais C., Carlson C., Hansen J., Rieder M., Robins H. Immunosequencing reveals diagnostic signatures of chronic viral infection in T cell memory. BioRxiv 2015, 10.1101/026567.
11. Gill S., June C.H. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunol. Rev. 2015, 263:68-89.
12. Gini C. Variabilità e mutabilità 1912, C. Cuppini, Bologna.
13. Gros A., Robbins P.F., Yao X., Li Y.F., Turcotte S., Tran E., Wunderlich J.R., Mixon A., Farid S., Dudley M.E., Hanada K., Almeida J.R., Darko S., Douek D.C., Yang J.C., Rosenberg S.A. PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest 2014, 124:2246-2259.
14. Howie B., Sherwood A.M., Berkebile A.D., Berka J., Emerson R.O., Williamson D.W., Kirsch I., M.V., Rieder M.J., Carlson C.S., HS.R. High-throughput pairing of T cell receptor alpha and beta sequences. Sci. Transl. Med. 2015, 7.
15. Kirsch I.R., Watanabe R., O'Malley J.T., Williamson D.W., Scott L.-L., Elco C.P., Teague J.E., Gehad A., Lowry E.L., LeBoeuf, Krueger J.G., Robins H.S., Kupper T.S., RA.C. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci. Transl. Med. 2015, (in press).
16. Kleinstein S.H., Louzoun Y., Shlomchik M.J. Estimating hypermutation rates from clonal tree data. J. Immunol. 2003, 171:4639-4649.
17. Klinger M., Kong K., Moorhead M., Weng L., Zheng J., Faham M. Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cells. PLoS One 2013, 8:e74231.
18. Korsmeyer S.J., Arnold A., Bakhshi A., Ravetch J.V., Siebenlist U., Hieter P.A., Sharrow S.O., LeBien T.W., Kersey J.H., Poplack D.G., Leder P., Waldmann T.A. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J. Clin. Invest 1983, 71:301-313.
19. Ladetto M., Bruggemann M., Monitillo L., Ferrero S., Pepin F., Drandi D., Barbero D., Palumbo A., Passera R., Boccadoro M., Ritgen M., Gokbuget N., Zheng J., Carlton V., Trautmann H., Faham M., Pott C. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia 2014, 28:1299-1307.
20. Maus M.V., Grupp S.A., Porter D.L., June C.H. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 2014, 123:2625-2635.
21. Pielou E.C. Species-diversity and pattern-diversity in the study of ecological succession. J. Theor. Biol. 1966, 10:370-383.
22. Robert L., Tsoi J., Wang X., Emerson R., Homet B., Chodon T., Mok S., Huang R.R., Cochran A.J., Comin-Anduix B., Koya R.C., Graeber T.G., Robins H., Ribas A. CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin. Cancer Res. 2014, 20:2424-2432.
23. Robins H. Immunosequencing: applications of immune repertoire deep sequencing. Curr. Opin. Immunol. 2013, 25:646-652.
24. Rosenberg S.A., Restifo N.P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015, 348:62-68.
25. Schumacher T.N., Schreiber R.D. Neoantigens in cancer immunotherapy. Science 2015, 348:69-74.
26. Shannon C.E. A mathematical theory of communication. Bell Syst. Tech. J. 1948, 27:379-423.
27. Sharma P., Allison J.P. The future of immune checkpoint therapy. Science 2015, 348:56-61.
28. Suessmuth Y., Mukherjee R., Watkins B., Koura D.T., Finstermeier K., Desmarais C., Stempora L., Horan J.T., Langston A., Qayed M., Khoury H.J., Grizzle A., Cheeseman J.A., Conger J.A., Robertson J., Garrett A., Kirk A.D., Waller E.K., Blazar B.R., Mehta A.K., Robins H.S., Kean L.S. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRbeta repertoire. Blood 2015, 125:3835-3850.
29. Sufficool K.E., Lockwood C.M., Abel H.J., Hagemann I.S., Schumacher J.A., Kelley T.W., Duncavage E.J. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. J. Am. Acad. Dermatol. 2015, 73:228-236.
30. Tumeh P.C., Harview C.L., Yearley J.H., Shintaku I.P., Taylor E.J., Robert L., Chmielowski B., Spasic M., Henry G., Ciobanu V., West A.N., Carmona M., Kivork C., Seja E., Cherry G., Gutierrez A.J., Grogan T.R., Mateus C., Tomasic G., Glaspy J.A., Emerson R.O., Robins H., Pierce R.H., ElashoffD.A., Robert C., Ribas A. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014, 515:568-571.
31. Uduman M., Shlomchik M.J., Vigneault F., Church G.M., Kleinstein S.H. Integrating B cell lineage information into statistical tests for detecting selection in Ig sequences. J. Immunol. 2014, 192:867-874.
32. van Doorn R., Van Haselen C.W., van Voorst Vader P.C., Geerts M.L., Heule F., de Rie M., Steijlen P.M., Dekker S.K., van Vloten W.A., Willemze R. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch. Dermatol. 2000, 136:504-510.
33. Wu D., Emerson R.O., Sherwood A., Loh M.L., Angiolillo A., Howie B., Vogt J., Rieder M., Kirsch I., Carlson C., Williamson D., Wood B.L., Robins H. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH. Clin. Cancer Res. 2014, 20:4540-4548.
34. Yaari G., Vander Heiden J.A., Uduman M., Gadala-Maria D., Gupta N., Stern J.N., O'Connor K.C., Hafler D.A., Laserson U., Vigneault F., Kleinstein S.H. Models of somatic hypermutation targeting and substitution based on synonymous mutations from high-throughput immunoglobulin sequencing data. Front Immunol. 2013, 4:358.
35. YousfiMonod M., Giudicelli V., Chaume D., Lefranc M.P. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics 2004, 1(20 Suppl):i379-385.